<DOC>
	<DOCNO>NCT02609126</DOCNO>
	<brief_summary>The main purpose study understand pharmacokinetics EP-104IAR determine whether safe use patient osteoarthritis ( OA ) knee . The study also provide preliminary insight whether experimental treatment reduces pain knee . Osteoarthritis common joint disease , affect 20 million people US alone . Currently , pain treatment inject directly knee often work short time may also side effect within rest body . The experimental treatment steroid family drug common current injectable treatment knee osteoarthritis . For study , drug coat polymer intend prolong time stay inside knee lessen potential side effect .</brief_summary>
	<brief_title>Safety Study Long-Acting Injectable Steroid Treat Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>OA Index Knee ≥6 month Kellgren Lawrence Grade 2 3 Patientreported pain ( PtPain ) Index Knee ≥4 ≤9 PtPain nonIndex Knee &lt; 4 BMI ≦ 40 kg/m2 Intraarticular joint injection Index Knee within past 8 week glucocorticoids 6 month hyaluronic acid Insulindependent diabetes Active infection Pregnant breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>osteoarthritis</keyword>
	<keyword>knee</keyword>
</DOC>